The Therapeutic Potential of Kiwi Extract as a Source of Cysteine Protease Inhibitors on DNCB-Induced Atopic Dermatitis in Mice and Human Keratinocyte HaCaT Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041534 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hye Ryeon Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Veterinary Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Keratinocytes, Actinidia, Cysteine Proteinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The discovery of effective cysteine protease inhibitors with crude protein kiwi extracts (CPKEs) has created novel challenges and prospects for pharmaceutical development. Despite extensive research on CPKEs, limited research has been conducted on treating atopic dermatitis (AD). Therefore, the objective of this work was to investigate the anti-inflammatory effects of CPKEs on TNF-α activation in a HaCaT cell model and in a DNCB (1-chloro-2, 4-dinitrochlorobenzene)-induced atopic dermatitis animal model. The molecular weight of the CPKE was determined using SDS-PAGE under non-reducing (17 kDa and 22 kDa) and reducing conditions (25 kDa, 22 kDa, and 15 kDa), whereas gelatin zymography was performed to examine the CPKE’s inhibitory impact on cysteine protease (actinidin and papain) activity. Moreover, the CPKE remains stable at 60 °C, with pH levels varying from 4 to 11, as determined by the azocasein assay. CPKE treatment decreased the phosphorylation of mitogen-activated protein kinase (MAPK) and Akt, along with the activation of nuclear factor-kappa B (NF-κB)-p65 in tumor necrosis factor-α (TNF-α)-stimulated HaCaT cells. Five-week-old BALB/c mice were treated with DNCB to act as an AD-like animal model. The topical application of CPKE to DNCB-treated mice for three weeks substantially decreased clinical dermatitis severity and epidermal thickness and reduced eosinophil infiltration and mast cells into ear and skin tissues. These findings imply that CPKE derived from kiwifruit might be a promising therapy option for inflammatory skin diseases such as AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Veterinary Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
- Institute of Animal Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
ORCID-Profile: Du Hyeon Hwang, Woo Hyun Kim, Jong-Hyun Kim, Euikyung Kim, Changkeun Kang
Förderung
- National Research Foundation of Korea
Zitieren
APA
Yang, H. R., Zahan, M. N., Hwang, D. H., Prakash, R. L. M., Ravi, D. A., Hong, I. H., Kim, W. H., Kim, J. H., Kim, E., & Kang, C. (2025). The Therapeutic Potential of Kiwi Extract as a Source of Cysteine Protease Inhibitors on DNCB-Induced Atopic Dermatitis in Mice and Human Keratinocyte HaCaT Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041534
Vancouver
Yang HR, Zahan MN, Hwang DH, Prakash RLM, Ravi DA, Hong IH, et al. The Therapeutic Potential of Kiwi Extract as a Source of Cysteine Protease Inhibitors on DNCB-Induced Atopic Dermatitis in Mice and Human Keratinocyte HaCaT Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041534
BibTeX
@article{Yang2025,
author = {Yang, Hye Ryeon and Zahan, Most Nusrat and Hwang, Du Hyeon and Prakash, Ramachandran Loganathan Mohan and Ravi, Deva Asirvatham and Hong, Il-Hwa and Kim, Woo Hyun and Kim, Jong-Hyun and Kim, Euikyung and Kang, Changkeun},
title = {The Therapeutic Potential of Kiwi Extract as a Source of Cysteine Protease Inhibitors on DNCB-Induced Atopic Dermatitis in Mice and Human Keratinocyte HaCaT Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041534}
}
EUVIMED